Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

58364 1487845784HCLSReviewSingaporeFeb2017.pdf
Energy Boardroom

Chinese investor puts up €25m to fund US heart failure trial

17.06.2014 / Scripintelligence

Belgian biotech firm Cardio3 BioSciences has signed a pair of deals with Chinese company Medisun International that secures €25m from Medisun to fund an FDA-approved US Phase III of C-Cure, Cardio3's cell therapy for heart failure, and sees the…

Cover_HCLS_Singapore LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: